Optimized development of a candidate strain of inactivated EV71 vaccine and analysis of its immunogenicity in rhesus monkeys

Human Vaccines

Volumn 6, Issue 12, 2010, Pages 1028-1037

  Dong, Chenghong ^a   Wang, Jingjing ^a   Liu, Longding ^a   Zhao, Hongling ^a   Liao, Yun ^a   Shi, Haijing ^a   Zhang, Ying ^a   Jiang, Li ^a   Li, Qihan ^a  

^a INSTITUTE OF MEDICAL BIOLOGY   (China)

Author keywords

Enterovirus type 71; Hand foot mouth disease; Immunogenicity; Inactivated vaccine; Rhesus monkey

Indexed keywords

INACTIVATED ENTEROVIRUS TYPE 71 VACCINE; INACTIVATED VIRUS VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; ENTEROVIRUS 71; ENTEROVIRUS INFECTION; GENETIC STABILITY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; MOLECULAR CLONING; MOUSE; NONHUMAN; RHESUS MONKEY; VACCINE PRODUCTION; VIROGENESIS; VIRUS INACTIVATION; VIRUS ISOLATION; VIRUS NEUTRALIZATION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TITRATION;

ANIMALS; ANTIBODIES, NEUTRALIZING; BASE SEQUENCE; CAPSID PROTEINS; CHINA; DISEASE MODELS, ANIMAL; ENTEROVIRUS A, HUMAN; GENOMIC INSTABILITY; HAND, FOOT AND MOUTH DISEASE; HUMANS; MACACA MULATTA; MOLECULAR SEQUENCE DATA; VACCINES, INACTIVATED; VIRAL VACCINES; VIRUS REPLICATION;

EID: 78751654405     PISSN: 15548600     EISSN: 15548619     Source Type: Journal    
DOI: 10.4161/hv.6.12.12982     Document Type: Article

References (31)

1. Ishimaru Y, Nakano S, Yamaoka K, Takami S. Outbreaks of hand, foot and mouth disease by enterovirus 71. High incidence of complication disorders of central nervous system. Arch Dis Child 1980; 55:13-5.
2. Brown BA, Oberste MS, Alexander JP Jr, Kennett ML, Pallansch MA. Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. J Virol 1999; 73:9969-75.
3. Schmidt NJ, Lennette EH, Ho HH. An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis 1974; 129:304-9.
4. Ho M. Enterovirus 71: the virus, its infections and outbreaks. J Microbiol Immunol Infect 2000; 33:205-16. (Pubitemid 32046397)
5. Ding NZ, Wang XM, Sun SW, Song Q, Li SN, He CQ. Appearance of mosaic enterovirus 71 in the 2008 outbreak of China. Virus Res 2009.
6. Bible JM, Pantelidis P, Chan PK, Tong CY. Genetic evolution of enterovirus 71: epidemiological and pathological implications. Rev Med Virol 2007; 17:371-9. (Pubitemid 350144562)
7. Huang FL, Jan SL, Chen PY, Chi CS, Wang TM, Fu YC, et al. Left ventricular dysfunction in children with fulminant enterovirus 71 infection: an evaluation of the clinical course. Clin Infect Dis 2002; 34:1020-4.
8. Perez-Velez CM, Anderson MS, Robinson CC, McFarland EJ, Nix WA, Pallansch MA, et al. Outbreak of neurologic enterovirus type 71 disease: a diagnostic challenge. Clin Infect Dis 2007; 45:950-7.
9. Liu CC, Tseng HW, Wang SM, Wang JR, Su IJ. An outbreak of enterovirus 71 infection in Taiwan 1998: epidemiologic and clinical manifestations. J Clin Virol 2000; 17:23-30.
10. Lin TY, Twu SJ, Ho MS, Chang LY, Lee CY. Enterovirus 71 outbreaks, Taiwan: occurrence and recognition. Emerg Infect Dis 2003; 9:291-3.
11. Chen SC, Chang HL, Yan TR, Cheng YT, Chen KT. An eight-year study of epidemiologic features of enterovirus 71 infection in Taiwan. Am J Trop Med Hyg 2007; 77:188-91.
12. Qiu J. Enterovirus 71 infection: a new threat to global public health? Lancet Neurol 2008; 7:868-9.
13. Ravindra KV, Wu S, Bozulic L, Xu H, Breidenbach WC, Ildstad ST. Composite tissue transplantation: a rapidly advancing field. Transplant Proc 2008; 40:1237-48. (Pubitemid 351853190)
14. Tung WS, Bakar SA, Sekawi Z, Rosli R. DNA vaccine constructs against enterovirus 71 elicit immune response in mice. Genet Vaccines Ther 2007; 5:6.
15. Lin YC, Wu CN, Shih SR, Ho MS. Characterization of a Vero cell-adapted virulent strain of enterovirus 71 suitable for use as a vaccine candidate. Vaccine 2002; 20:2485-93.
16. Arita M, Ami Y, Wakita T, Shimizu H. Cooperative effect of the attenuation determinants derived from poliovirus sabin 1 strain is essential for attenuation of enterovirus 71 in the NOD/SCID mouse infection model. J Virol 2008; 82:1787-97.
17. Wu CN, Lin YC, Fann C, Liao NS, Shih SR, Ho MS. Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus. Vaccine 2001; 20:895-904.
18. Ong KC, Devi S, Cardosa MJ, Wong KT. Formaldehyde-inactivated whole-virus vaccine protects a murine model of enterovirus 71 encephalomyelitis against disease. J Virol 2010; 84:661-5.
19. Liu LD, Wang LC, Dong CH, Wang JJ, Li QH. Rhesus monkey as a model of enterovirus 71 infection with pulmonary injury. Vaccine 2010; In submission.
20. Huang F, Li WH, Tan XJ. [Genetic analysis of VP1 sequences of enterovirus 71 isolated from patients of hand, foot and mouth disease in Beijing 2008]. Zhongguo Ji Hua Mian Yi 2009; 15:527-30.
21. Nagata N, Iwasaki T, Ami Y, Tano Y, Harashima A, Suzaki Y, et al. Differential localization of neurons susceptible to enterovirus 71 and poliovirus type 1 in the central nervous system of cynomolgus monkeys after intravenous inoculation. J Gen Virol 2004; 85:2981-9.
22. Mizuta K, Aoki Y, Suto A, Ootani K, Katsushima N, Itagaki T, et al. Cross-antigenicity among EV71 strains from different genogroups isolated in Yamagata, Japan, between 1990 and 2007. Vaccine 2009; 27:3153-8.
23. Chen YC, Yu CK, Wang YF, Liu CC, Su IJ, Lei HY. A murine oral enterovirus 71 infection model with central nervous system involvement. J Gen Virol 2004; 85:69-77. (Pubitemid 38128871)
24. McMinn PC. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev 2002; 26:91-107. (Pubitemid 34454778)
25. Alejska M, Kurzyniska-Kokorniak A, Broda M, Kierzek R, Figlerowicz M. How RNA viruses exchange their genetic material. Acta Biochim Pol 2001; 48:391-407. (Pubitemid 33638623)
26. Iakovenko ML, Korotkova EA. [Evolution of vaccine poliovirus strains]. Vopr Virusol 2008; 53:45-8.
27. Chinese Pharmacopoeia Commission, Pharmacopoeia of the People's Republic of China (chinese), Part I. People's Medical Publishing House 2005; 3:14-8.
28. Mao JS, Dong DX, Zhang HY, Chen NL, Zhang XY, Huang HY, et al. Primary study of attenuated live hepatitis A vaccine (H2 strain) in humans. J Infect Dis 1989; 159:621-4.
29. Sever JL. Application of a microtechnique to viral serological investigations. J Immunol 1962; 88:320-9.
30. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76:4350-4.
31. Gorska P. Principles in laboratory animal research for experimental purposes. Med Sci Monit 2000; 6:171-80.